Clinical trial

Treatment of Schizophrenic Patients With Ziprasidone

NCT00579670

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-10-01

PhaseN/A

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2021-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

ZiprasidoneDRUG · verified · RxNorm: ziprasidone

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Mapped research locations

ThessalonikiGreece3 AthensGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00579670 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.